Overwhelmed by Heterologous Elements: The Hidden Identity of an Ovarian Sertoli–Leydig Cell Tumor with Extensive Heterologous Elements
DOI:
https://doi.org/10.21276/apalm.3826Keywords:
sertoli–leydig cell tumor, ovary, heterologous elements, immunohistochemistryAbstract
Background: Sertoli–Leydig cell tumors (SLCTs) are rare ovarian sex cord–stromal tumors, often presenting diagnostic challenges due to their varied morphology and association with heterologous elements.
Case Presentation: We report a case of 21-year-old female presenting with pelvic pain, secondary amenorrhea, and virilization. Radiology revealed a left ovarian mass. Patient underwent fertility sparing left partial oophorectomy. Histopathological examination demonstrated extensive calcification and ossification with scanty tumor cells, posing significant diagnostic difficulty. Based on morphology differential included were mesenchymal tumors of ovary, mature teratoma and sex cord stromal tumors. Immunohistochemistry played a crucial role in establishing the diagnosis of Sertoli–Leydig cell tumor with extensive heterologous elements.
Conclusion: This case highlights the importance of correlating morphology, immunohistochemistry, and clinical features to arrive at an accurate diagnosis, especially in tumors with dominant heterologous components.
References
1. WHO Classification of Tumours Editorial Board. Female genital tumours. 5th ed. Lyon: International Agency for Research on Cancer; 2020. (WHO classification of tumours series).
2. Bekker P, Miland-Samuelsen AR, Smerdel MP, Schnack TH, Lauszus FF, Karstensen SH. Sertoli-Leydig cell tumor: a clinicopathological analysis in a comprehensive national cohort. Int J Gynecol Cancer. 2023;33(12):1921–1927. doi:10.1136/ijgc-2023-004945.
3. Wang G, Zhang R, Li C, Chen A. Characteristics and outcomes analysis of ovarian Sertoli-Leydig cell tumors (SLCTs): analysis of 15 patients. J Ovarian Res. 2021;14(1):150. doi:10.1186/s13048-021-00909-7.
4. Žilinskienė G, Bužinskienė D, Šidlovska E, Rudaitis V. An ovarian Sertoli–Leydig cell tumor with elevated alpha-fetoprotein in an adolescent: a rare case report and literature review. Medicina (Kaunas). 2024;60:1477. doi:10.3390/medicina60091477.
5. Castrichini K, Piris KM, Kessen A, Novo P, Rojas A, Padhy R, Bonilla A, Jahoda J, Aziz M. Case study. GSC Adv Res Rev. 2025;24(2):232–239. doi:10.30574/gscarr.2025.24.2.0249.
6. Trecourt A, Scard C, Descotes F, Lopez J, Treilleux I, Averous G, Illac-Vauquelin C, Bataillon G, Loussouarn D, Dijoud F, Ray-Coquard I, You B, Alix E, Gertych W, Genestie C, Devouassoux-Shisheboran M. Molecular relationship between ovarian Sertoli-Leydig cell tumors and their heterologous elements: emphasis on the possible prognostic significance of TERT pathogenic variants. Am J Surg Pathol. 2026;50(2):232–246. doi:10.1097/PAS.0000000000002493.
7. Fang C, Chen H, Zhou Y, Xiao H, Xu B. Current status of treatment for malignant ovarian sex cord-stromal tumors. Discover Oncology. 2024;15:799. doi:10.1007/s12672-024-01687-6.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Sudharani Hanumanthu, Sujit Joshi, Gourav Agrawal, Nidhi Bandiwadekar
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
How to Cite
